สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - Ónæmiskerfið sera og mótefni, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroxat filmuhúðuð tafla 20 mg
glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 20 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroxat filmuhúðuð tafla 10 mg
glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 10 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
engerix b stungulyf, dreifa
glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix polio stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
duodart hart hylki 0,5/0,4 mg
glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
menveo
gsk vaccines s.r.l. - meningókokka hóp a, c, w-135 og y samtengd bóluefni - immunization; meningitis, meningococcal - bakteríubóluefni - vialsmenveo er ætlað fyrir virk bólusetningar sem börn (frá tveggja ára aldri), unglingum og fullorðnir í hættu af völdum neisseria meningitidis tekur, c, w135 og y, til að koma í veg fyrir innrásar sjúkdómur. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
wellbutrin retard (lyfjaver) tafla með breyttan losunarhraða 150 mg
lyfjaver ehf. - bupropionum inn hýdróklóríð - tafla með breyttan losunarhraða - 150 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
wellbutrin retard (lyfjaver) tafla með breyttan losunarhraða 300 mg
lyfjaver ehf. - bupropionum inn hýdróklóríð - tafla með breyttan losunarhraða - 300 mg